Time- and Dose-Resolved Proteome of PM_2.5-Exposure-Induced Lung Injury and Repair in Rats 由 Fan Zhang (46132)

Time- and Dose-Resolved Proteome of PM_2.5-Exposure-Induced Lung Injury and Repair in Rats 由 Fan Zhang (46132)

Time- and Dose-Resolved Proteome of PM_2.5-Exposure-Induced Lung Injury and Repair in Rats 由 Fan Zhang (46132)

Time- and Dose-Resolved Proteome of PM_2.5-Exposure-Induced Lung Injury and Repair in Rats 由 Fan Zhang (46132)

Time- and Dose-Resolved Proteome of PM_2.5-Exposure-Induced Lung Injury and Repair in Rats 由 Fan Zhang (46132)

In-situ time resolved spectrographic measurement using an additively manufactured metallic micro-fluidic analysis platform - Fig 2 由 T. W. Monaghan (8038769)

In-situ time resolved spectrographic measurement using an additively manufactured metallic micro-fluidic analysis platform - Fig 5 由 T. W. Monaghan (8038769)

In-situ time resolved spectrographic measurement using an additively manufactured metallic micro-fluidic analysis platform - Fig 3 由 T. W. Monaghan (8038769)

Workflow of the phases involved. 由 Wan Nor Atikah Che Wan Mohd Rozali (19746296)

“...While the third phase involved evaluating the reliability. A total of six experts from public academic institutions participated in the initial evaluation stage to assess validity while five experts were involved in the second stage. ...”

Network plot of clonal clusters (0.99 IBD) harboring distinct haplotypes for four main genes involved in antimalarial drug resistance. 由 Manuela Carrasquilla (2897933)

主題:

Medications involved in medication-related incidents. 由 Philippa Rees (3662989)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. 由 Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. 由 Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. 由 Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... 由 Diana M. Hendrickx (1507435)